• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非靶向代谢组学和蛋白质组学分析表明,SIRT2是糖尿病肾病的一个新的治疗靶点。

Untargeted metabolomic and proteomic analysis implicates SIRT2 as a novel therapeutic target for diabetic nephropathy.

作者信息

Zhang Ruijing, Chang Runze, Wang Heng, Chen Jinshan, Lu Chuanlong, Fan Keyi, Zhang Yuhang, Li Lizheng, Yan Sheng, Dong Honglin

机构信息

Department of Nephrology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.

Department of Vascular Surgery, The Second Hospital of Shanxi Medical University, Wuyi Road No. 382, Taiyuan, 030001, Shanxi, People's Republic of China.

出版信息

Sci Rep. 2025 Feb 4;15(1):4236. doi: 10.1038/s41598-024-80492-1.

DOI:10.1038/s41598-024-80492-1
PMID:39905044
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11794435/
Abstract

Diabetic nephropathy (DN) is one of the major causes of end-stage renal disease. This study aimed to explore the internal relationship between metabolic processes and autoimmune responses in patients with DN via untargeted metabolomics and Olink proteomics. The serum of 10 patients who were diagnosed with DN and 10 healthy individuals via untargeted metabolomics and Olink proteomics. Animal models were used to validate the characterized genes. Correlation analysis of major differentially abundant metabolites and differentially expressed proteins revealed that SIRT2 might be a key hub linking energy metabolism and innate immune responses. KEGG enrichment analysis showed that HIF-1 signaling pathway and renal cell carcinoma pathway were co-enriched pathways in energy metabolism and inflammatory response. VEGFA plays a vital role in these two signaling pathways. The ability of SIRT2 to regulate VEGFA expression has been demonstrated. In vivo experiments revealed that SIRT2, VEGFA, and HIF-1α were highly expressed in the kidneys of mice with diabetic nephropathy. In conclusion, our study combines metabolomics and proteomics to provide valuable insights into the synergistic roles of metabolic disorders and inflammatory responses in DN. The data suggest that SIRT2 may be a key target affecting these processes.

摘要

糖尿病肾病(DN)是终末期肾病的主要病因之一。本研究旨在通过非靶向代谢组学和Olink蛋白质组学探索DN患者代谢过程与自身免疫反应之间的内在关系。通过非靶向代谢组学和Olink蛋白质组学分析了10例经诊断患有DN的患者和10例健康个体的血清。使用动物模型验证所鉴定的基因。主要差异丰富代谢物和差异表达蛋白质的相关性分析表明,SIRT2可能是连接能量代谢和先天性免疫反应的关键枢纽。KEGG富集分析表明,缺氧诱导因子-1(HIF-1)信号通路和肾细胞癌通路是能量代谢和炎症反应中的共同富集通路。血管内皮生长因子A(VEGFA)在这两条信号通路中起重要作用。已证实SIRT2具有调节VEGFA表达的能力。体内实验表明,SIRT2、VEGFA和HIF-1α在糖尿病肾病小鼠的肾脏中高表达。总之,我们的研究结合代谢组学和蛋白质组学,为代谢紊乱和炎症反应在DN中的协同作用提供了有价值的见解。数据表明,SIRT2可能是影响这些过程的关键靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caaa/11794435/33844ba42054/41598_2024_80492_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caaa/11794435/aacafdb536fc/41598_2024_80492_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caaa/11794435/65c71fdf8bc9/41598_2024_80492_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caaa/11794435/8d1062ba36c2/41598_2024_80492_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caaa/11794435/80a630ba53eb/41598_2024_80492_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caaa/11794435/45d976263efc/41598_2024_80492_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caaa/11794435/f077e1a67159/41598_2024_80492_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caaa/11794435/33844ba42054/41598_2024_80492_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caaa/11794435/aacafdb536fc/41598_2024_80492_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caaa/11794435/65c71fdf8bc9/41598_2024_80492_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caaa/11794435/8d1062ba36c2/41598_2024_80492_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caaa/11794435/80a630ba53eb/41598_2024_80492_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caaa/11794435/45d976263efc/41598_2024_80492_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caaa/11794435/f077e1a67159/41598_2024_80492_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caaa/11794435/33844ba42054/41598_2024_80492_Fig7_HTML.jpg

相似文献

1
Untargeted metabolomic and proteomic analysis implicates SIRT2 as a novel therapeutic target for diabetic nephropathy.非靶向代谢组学和蛋白质组学分析表明,SIRT2是糖尿病肾病的一个新的治疗靶点。
Sci Rep. 2025 Feb 4;15(1):4236. doi: 10.1038/s41598-024-80492-1.
2
Sirtuin 2 exacerbates renal tubule injury and inflammation in diabetic mice via deacetylation of c-Jun/c-Fos.沉默调节蛋白2通过使c-Jun/c-Fos去乙酰化加重糖尿病小鼠的肾小管损伤和炎症。
Cell Mol Life Sci. 2025 Jan 21;82(1):45. doi: 10.1007/s00018-024-05567-8.
3
[Effect of Cordyceps sinensis on expressions of HIF-1α and VEGF in the kidney of rats with diabetic nephropathy].[冬虫夏草对糖尿病肾病大鼠肾脏中HIF-1α和VEGF表达的影响]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013 May;38(5):448-57. doi: 10.3969/j.issn.1672-7347.2013.05.003.
4
Effect of extract of Pueraria tuberosa on expression of hypoxia inducible factor-1α and vascular endothelial growth factor in kidney of diabetic rats.野葛提取物对糖尿病大鼠肾脏低氧诱导因子-1α和血管内皮生长因子表达的影响。
Biomed Pharmacother. 2017 Sep;93:276-285. doi: 10.1016/j.biopha.2017.06.045. Epub 2017 Jun 23.
5
MicroRNA-122-5p ameliorates tubular injury in diabetic nephropathy via FIH-1/HIF-1α pathway.微小 RNA-122-5p 通过 FIH-1/HIF-1α 通路改善糖尿病肾病的肾小管损伤。
Ren Fail. 2022 Dec;44(1):293-303. doi: 10.1080/0886022X.2022.2039194.
6
Proteomic profiling of laser capture microdissection kidneys from diabetic nephropathy patients.激光捕获微切割糖尿病肾病患者肾脏的蛋白质组学分析。
J Chromatogr B Analyt Technol Biomed Life Sci. 2024 Aug 1;1243:124231. doi: 10.1016/j.jchromb.2024.124231. Epub 2024 Jul 5.
7
Connexin 43 prevents the progression of diabetic renal tubulointerstitial fibrosis by regulating the SIRT1-HIF-1α signaling pathway.缝隙连接蛋白 43 通过调节 SIRT1-HIF-1α 信号通路来防止糖尿病肾间质纤维化的进展。
Clin Sci (Lond). 2020 Jul 17;134(13):1573-1592. doi: 10.1042/CS20200171.
8
SIRT2 inhibition activates hypoxia-inducible factor 1α signaling and mediates neuronal survival.SIRT2 抑制激活缺氧诱导因子 1α 信号通路并介导神经元存活。
Biochem Biophys Res Commun. 2020 Sep 3;529(4):957-962. doi: 10.1016/j.bbrc.2020.06.159. Epub 2020 Jul 30.
9
Metabolomics and molecular dynamics unveil the therapeutic potential of epalrestat in diabetic nephropathy.代谢组学和分子动力学揭示依帕司他在糖尿病肾病中的治疗潜力。
Int Immunopharmacol. 2024 Oct 25;140:112812. doi: 10.1016/j.intimp.2024.112812. Epub 2024 Aug 1.
10
Interstitial HIF1A induces an estimated glomerular filtration rate decline through potentiating renal fibrosis in diabetic nephropathy.间质 HIF1A 通过增强糖尿病肾病中的肾纤维化导致估计肾小球滤过率下降。
Life Sci. 2020 Jan 15;241:117109. doi: 10.1016/j.lfs.2019.117109. Epub 2019 Nov 28.

引用本文的文献

1
Interplay of hypoxia, immune dysregulation, and metabolic stress in pathophysiology of type 1 diabetes.1型糖尿病病理生理学中缺氧、免疫失调和代谢应激的相互作用
Front Immunol. 2025 Jun 4;16:1599321. doi: 10.3389/fimmu.2025.1599321. eCollection 2025.

本文引用的文献

1
Phenotypic Versus Genetic Mismatch of BMI and Type 2 Diabetes: Evidence From Two Prospective Cohort Studies.体重指数与2型糖尿病的表型与基因不匹配:来自两项前瞻性队列研究的证据。
Diabetes. 2025 Mar 1;74(3):320-331. doi: 10.2337/db24-0736.
2
A novel mechanism of sodium and fluid retention in liver disease.肝病中钠和液体潴留的一种新机制。
Nat Rev Nephrol. 2024 Oct;20(10):635. doi: 10.1038/s41581-024-00892-4.
3
New insight into arginine and tryptophan metabolism in macrophage activation during tuberculosis.在结核分枝杆菌感染过程中,巨噬细胞活化的精氨酸和色氨酸代谢的新见解。
Front Immunol. 2024 Apr 2;15:1363938. doi: 10.3389/fimmu.2024.1363938. eCollection 2024.
4
Exploratory study of blood biomarkers in patients with post-stroke epilepsy.卒中后癫痫患者血液生物标志物的探索性研究。
Eur Stroke J. 2024 Sep;9(3):763-771. doi: 10.1177/23969873241244584. Epub 2024 Apr 1.
5
Sex differences in kidney metabolism and DKD.肾脏代谢与糖尿病肾病中的性别差异。
Nat Rev Nephrol. 2024 May;20(5):271. doi: 10.1038/s41581-024-00832-2.
6
Development and External Validation of Machine Learning Models for Diabetic Microvascular Complications: Cross-Sectional Study With Metabolites.机器学习模型在糖尿病微血管并发症中的开发和外部验证:基于代谢物的横断面研究。
J Med Internet Res. 2024 Mar 28;26:e41065. doi: 10.2196/41065.
7
Recent Advances in the Management of Diabetic Kidney Disease: Slowing Progression.糖尿病肾病管理的最新进展:减缓进展。
Int J Mol Sci. 2024 Mar 7;25(6):3086. doi: 10.3390/ijms25063086.
8
Proteomic profiles of left atrial volume and its influence on response to spironolactone: Findings from the HOMAGE trial and STANISLAS cohort.左房容积的蛋白质组学特征及其对螺内酯反应的影响:来自 HOMAGE 试验和 STANISLAS 队列的研究结果。
Eur J Heart Fail. 2024 May;26(5):1231-1241. doi: 10.1002/ejhf.3202. Epub 2024 Mar 25.
9
The association between interleukin family and diabetes mellitus and its complications: An overview of systematic reviews and meta-analyses.白细胞介素家族与糖尿病及其并发症的关联:系统评价和荟萃分析综述。
Diabetes Res Clin Pract. 2024 Apr;210:111615. doi: 10.1016/j.diabres.2024.111615. Epub 2024 Mar 19.
10
Clinical metabolomics characteristics of diabetic kidney disease: A meta-analysis of 1875 cases with diabetic kidney disease and 4503 controls.临床代谢组学在糖尿病肾病中的特征:对 1875 例糖尿病肾病患者和 4503 例对照的荟萃分析。
Diabetes Metab Res Rev. 2024 Mar;40(3):e3789. doi: 10.1002/dmrr.3789.